quinazolines has been researched along with 2-phenylquinazoline in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Brown, P; Chen, B; Cope, H; Heal, W; Mutter, R; Pascoe, C; Pratt, S | 1 |
Chakraborty, R; Ganguli, S; Nanda, AK | 1 |
ENDICOTT, MM; WICK, E | 1 |
Choo, HY; Kwon, YJ; Lee, E; Lee, YS; Rhee, HK; Seo, HR; Yoo, JH | 1 |
Bera, S; Biswas, SK; Bose, D; Chatterjee, N; Das Saha, K; Das, S; Dey, SK; Munda, RN; Nandy, A | 1 |
Banerjee, S; Bose, D; Chatterjee, N; Chattopadhyay, D; Das, S; Saha, KD | 1 |
Juvale, K; Wiese, M | 1 |
Alsaid, MS; Arafa, RK; Dinkova-Kostova, AT; Elghazawy, NH; Ghorab, MM; Higgins, M; Shahat, AA | 1 |
Baranwal, S; Dwivedi, AR; Kumar, N; Kumar, V; Prasad, A; Rawat, SS; Yadav, RP | 1 |
9 other study(ies) available for quinazolines and 2-phenylquinazoline
Article | Year |
---|---|
Synthesis and SAR study of acridine, 2-methylquinoline and 2-phenylquinazoline analogues as anti-prion agents.
Topics: Acridines; Animals; Binding, Competitive; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Mice; Molecular Structure; Prions; Quinaldines; Quinazolines; Stereoisomerism; Structure-Activity Relationship | 2006 |
Antibacterial activity of some 3-(arylideneamino)-2-phenylquinazoline-4(3H)-ones: synthesis and preliminary QSAR studies.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Escherichia coli; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Quantitative Structure-Activity Relationship; Quinazolines; Shigella dysenteriae; Staphylococcus aureus | 2007 |
Quinazoline derivatives; the synthesis of 4-(4'-diethylamino-1'-methylbutylamino)-quinazoline (SN 11,534) and the corresponding 2-phenylquinazoline (SN 11,535).
Topics: Quinazolines | 1946 |
Synthesis and cytotoxicity of 2-phenylquinazolin-4(3H)-one derivatives.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Magnetic Resonance Spectroscopy; Quinazolines; Spectrometry, Mass, Fast Atom Bombardment; Spectrophotometry, Infrared; Structure-Activity Relationship | 2011 |
Anticancer potential of 3-(arylideneamino)-2-phenylquinazoline-4(3H)-one derivatives.
Topics: Animals; Annexin A5; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Shape; Cytochromes c; DNA Fragmentation; G1 Phase Cell Cycle Checkpoints; HCT116 Cells; HeLa Cells; Humans; Membrane Potential, Mitochondrial; Mice; Neoplasms; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Quinazolines; Transplantation, Heterologous | 2012 |
Exploring the anti-inflammatory activity of a novel 2-phenylquinazoline analog with protection against inflammatory injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Capillary Permeability; Carrageenan; Cell Line; Cell Survival; Cytokines; Dinoprostone; Female; Formaldehyde; Inflammation; Lipopolysaccharides; Liver; Liver Function Tests; Macrophages; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; NF-kappa B; Nitric Oxide; Quinazolines; Shock, Septic; Survival | 2012 |
4-Substituted-2-phenylquinazolines as inhibitors of BCRP.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Female; Humans; Inhibitory Concentration 50; Molecular Structure; Neoplasm Proteins; Protein Binding; Quinazolines | 2012 |
Synthesis, molecular modeling and NAD(P)H:quinone oxidoreductase 1 inducer activity of novel 2-phenylquinazolin-4-amine derivatives.
Topics: Amines; Animals; Carbon-13 Magnetic Resonance Spectroscopy; Cell Line, Tumor; Enzyme Induction; Mass Spectrometry; Mice; Models, Molecular; NAD(P)H Dehydrogenase (Quinone); Proton Magnetic Resonance Spectroscopy; Quinazolines | 2016 |
Benzotriazole Substituted 2-Phenylquinazolines as Anticancer Agents: Synthesis, Screening, Antiproliferative and Tubulin Polymerization Inhibition Activity.
Topics: Antineoplastic Agents; Cell Proliferation; Drug Screening Assays, Antitumor; HEK293 Cells; Humans; Molecular Docking Simulation; Polymerization; Quinazolines; Structure-Activity Relationship; Tubulin | 2023 |